held by the American Association for the Study of Liver Diseases. Using a survey of a nationally representative sample of ...

Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company pioneering regenerative macrophage therapies in inflammatory and fibrotic diseases, today announces it has ...

who discussed their findings at the November 15-19 meeting of the American Association for the Study of Liver Diseases. The ...

Given the increasing prevalence and mortality rates, targeted strategies are needed to reduce this growing health burden in ...

AI can help doctors diagnose early cases of fatty liver disease, a new study says. An AI program trained to spot a leading ...

So, drinkers of the cheaper industrial brands are probably poorer, and as other sociological studies have shown, probably ...

There aren't many biotechs that are more exciting than Viking Therapeutics (NASDAQ: VKTX) right now. Thanks to its ...

Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the ...

Liver biomarkers at baseline in addition to changes during follow-up are associated with cirrhosis and HCC in HDV.

Sarcopenia is not associated with waitlist mortality and does not appear to affect postliver transplantation survival.